Latest filing published 30 Sept 2025 for Nexalin Technology, Inc.. Read the official filing
Leonard Osser (senior executive) discloses dealings in 2 companies, chiefly Milestone Scientific Inc. and Nexalin Technology, Inc. The record holds 31 filings, for trades running from 21 June 2021 to 29 September 2025.
No open-market purchase appears, only 22 sales worth €380k. Besides market trades, the filings include 7 share grants and 2 option exercises.
The newest entry dates from 30 September 2025: a share grant, in Nexalin Technology, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations